Wellcome Trust extends funding initiative for early stage drug discovery
This article was originally published in Scrip
The Wellcome Trust will continue to help fund the early stages of drug discovery for another five years by extending its Seeding Drug Discovery initiative with a further £110 million.
You may also be interested in...
Canadian Action On Rare Disease Is A ‘Step Forward,’ Says Industry
Canadian rare disease drugs strategy is expected to improve access to treatments and the collection and use of real-world evidence.
Novo Nordisk Hit With UK Industry Association Suspension Over Weight Loss Drug Promotion
Novo Nordisk has been hit by a serious sanction in the UK after having been found to effectively pay pharmacists to promote Saxenda.
UK ABPI Suspends Novo Nordisk Over Code Breach
Novo Nordisk has been given a two-year suspension from membership of the Association of the British Pharmaceutical Industry for breaching the association’s code of practice.